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Abstract
Background: Despite the current debate about the effects of high intensity interval training (HIIT), HIIT elicits big
morpho-physiological benefit on Metabolic Syndrome (MetS) treatment. However, no review or meta-analysis has
compared the effects of HIIT to non-exercising controls in MetS variables. The aim of this study was to determine
through a systematic review, the effectiveness of HIIT on MetS clinical variables in adults.
Methods: Studies had to be randomised controlled trials, lasting at least 3 weeks, and compare the effects of HIIT
on at least one of the MetS clinical variables [fasting blood glucose (BG), high-density lipoprotein (HDL-C)
triglyceride (TG), systolic (SBP) or diastolic blood pressure (DBP) and waist circumference (WC)] compared to a
control group. The methodological quality of the studies selected was evaluated using the PEDro scale.
Results: Ten articles fulfilled the selection criteria, with a mean quality score on the PEDro scale of 6.7. Compared
with controls, HIIT groups showed significant and relevant reductions in BG (− 0.11 mmol/L), SBP (− 4.44 mmHg),
DBP (− 3.60 mmHg), and WC (− 2.26 cm). Otherwise, a slight increase was observed in HDL-C (+ 0.02 mmol/L). HIIT
did not produce any significant changes in TG (− 1.29 mmol/L).
Conclusions: HIIT improves certain clinical aspects in people with MetS (BG, SBP, DBP and WC) compared to
people with MetS who do not perform physical exercise. Plausible physiological changes of HIIT interventions
might be related with large skeletal muscle mass implication, improvements in the vasomotor control, better
baroreflex control, reduction of the total peripheral resistance, increases in excess post-exercise oxygen
consumption, and changes in appetite and satiety mechanisms.
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Background
Despite the efforts from national and international bod-
ies to promote healthy behaviours and prevent physical
inactivity, global physical inactivity levels have failed to
come down over the last decade [1, 2]. In 2016, global
physical inactivity prevalence was 27.5%, which means
that more than one of every four adults do not meet the
minimum recommended physical activity levels [3, 4].
Not meeting the recommended levels of physical activity
increases the risk of developing chronic diseases such as
obesity, hypertension, type 2 diabetes, osteoporosis, and
cancer, and increases the mortality risk [5, 6].
Within these diseases, Metabolic Syndrome (MetS) has
one of the highest mortality rates [7]. MetS is defined as
a cluster of cardiovascular risk factors that includes ele-
vated blood glucose (BG), low high-density lipoprotein
(HDL-C), high triglycerides (TG) levels, high systolic
blood pressure (SBP), high diastolic blood pressure
(DBP) and increased waist circumference (WC) [8]. It is
further agreed that an individual is diagnosed with MetS
when three or more of the aforementioned risk factors
are present. Even though MetS is responsible for many
deaths, it is a condition that is underdiagnosed and
therefore undertreated because it is largely asymptom-
atic [9]. For example, the reported prevalence of MetS in
the United States is 35%, however this figure rises to
50% for adults aged 60 and over [10, 11]. In this regard,
MetS is a strong predictor of cardiovascular and all-
cause mortality. Thus, it is imperative to diagnose and
treat individuals with metabolic syndrome effectively
[12–14].
The standard treatment for MetS is to prescribe phar-
maceuticals for the treatment of the individual risk factors
(i.e. hypertension, diabetes, etc), which also brings poten-
tially adverse side effects, such as gastrointestinal prob-
lems, arrhythmias, weight gain, insomnia, dizziness,
asthenia, etc. [15, 16]. However, evidence suggests that an
appropriate lifestyle can help manage and prevent MetS
and its associated factors [17]. More specifically, daily
physical activity (PA) has been shown to reduce most of
the MetS risk factors, and therefore MetS itself [18, 19].
Thus, exercise prescription should be considered as a
non-pharmacological, non-invasive, first-line, low-cost
treatment to improve MetS. There is evidence that shows
strong links between exercise and reducing the prevalence
of MetS [20], likely a result of increased caloric expend-
iture and structural changes in muscle [21, 22].
Lack of time is often cited as one of the main reasons
not to meet the recommended PA levels [23]. Because of
the time constraints, there is a growing interest in devel-
oping alternative approaches to exercise that require
shorter work times and lower training volumes, yet still
elicit physiological benefits similar to more traditional
exercise bouts.
High Intensity Interval Training (HIIT) on MetS is be-
lieved to be one of the most time-efficient training
modes that have been recently developed [24]. HIIT
consists of bouts of exercise at high intensity inter-
spersed by periods of active/passive recovery. HIIT train-
ing combinations, by modifying work and rest ratios, are
infinite. With shorter training times, it has been sug-
gested that HIIT training can induce similar benefits as
prolonged training on cardiorespiratory fitness and
muscle oxidative capacity [25, 26].
Nonetheless the prescription of HIIT to inactive indi-
viduals that suffer MetS is not without controversy [27],
as HIIT is deemed unsafe by some authors. In the litera-
ture, we find that after 24 h after a bout of HIIT in pa-
tients with cardiometabolic diseases, the adverse
responses (cardiac arrest or myocardial infarction) to
HIIT is around 8% (most of them were mild in nature),
which is slightly higher than seen after Moderate Inten-
sity Continuous Training (MICT) [28]. Although caution
must be taken before high intensity training in people
with cardiovascular diseases, recent systematic reviews
of randomised controlled trials found that the number
of adverse events is low [29, 30] and these percentages
are much lower in asymptomatic people [31, 32], so this
type of training could classified as safe under supervi-
sion. In addition to suggesting that HIIT is potentially
less safe than MICT, some authors believe that HIIT will
not have a public health impact because it is too de-
manding, eliciting low enjoyment levels and that current
inactive people will not adhere to HIIT on the long
term, only active individuals will take up this mode of
exercise [27]. On the other hand, those that points out
HIIT as a promising opportunity to promote a more ac-
tive behaviour, say that the traditional forms of exercise,
including MICT, have been a failure [27]. In regard to
behaviour, several studies have reported that HIIT usu-
ally offers more enjoyment and affective responses both
during and immediately after exercise [33]. Therefore,
HIIT may be an alternative to MICT for inducing posi-
tive physiological adaptations [28] and doing so in a
more enjoyable way [27].
For these reasons there has been an increase in ar-
ticles published on the effects HIIT has on popula-
tions with various chronic diseases, including MetS.
Recent studies seem to find that HIIT elicits big
morpho-physiological benefit on MetS treatment.
Previous reviews have compared the effects HIIT
and MICT have on MetS and in single cardiovascu-
lar risk factors, and all are in agreement that HIIT
can produce similar health benefits in MetS compo-
nents compared to MICT, yet in a shorter time
frame [34–36]. However, to date, no review or meta-
analysis has compared the effects of HIIT to non-
exercising controls in MetS variables.
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Therefore, the purpose of this meta-analysis is to re-
view the literature of randomised controlled trials (RCT)
in regard to the effectiveness of HIIT interventions on
MetS variables (BG, HDL-C, TG, SBP, DBP, and WC) in
adults compared to non-exercise controls.
Methods
In order to accomplish our objectives, this review
followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines [37].
PRISMA checklist can be found in Appendix 1.
Study selection and eligibility criteria
To be included in the meta-analysis, each study had to
fulfil the following criteria: a) Studies had to be rando-
mised controlled trials (RCT), lasting at least 3 weeks,
that analysed the effects of HIIT in at least one variable
of MetS (BG, HDL-C, TG, SBP, DBP and/or WC) in
people with MetS [8] (Table 1); b) all participants in the
studies had to be aged ≥18 years;; c) sample size in the
post-test had to be higher than 4 participants per group;
d) studies had to include a non-exercising control group;
e) studies had to report enough statistical data to calcu-
late the effect sizes; f) studies had to be published before
January 2020; and g) studies had to be written in English
or Spanish. Animal studies, review articles, acute exer-
cise studies, and nonrandomised-controlled trials were
excluded.
Search strategy
Potential studies were identified using a systematic
search process. First, the following bibliographical data-
bases were searched: Cochrane Library, Embase,
PubMed, Sportdiscus, and Web of Science, with the fol-
lowing search terms included in Boolean search strat-
egies: (metabolic syndrome [tiab] OR metabolic
syndrome [mesh] OR comorbidities [tiab] OR comorbid-
ities [mesh] OR cardiometabolic disease [tiab] OR car-
diometabolic disease [mesh]) AND (HIIT [tiab] OR
HIIT [mesh] OR high intensity interval training [tiab]
OR high intensity interval training [mesh] OR interval
training [tiab] OR interval training [mesh]).
The search was limited to publication dates (to “De-
cember 31st, 2019”). The reference lists of the studies re-
covered were hand searched to identify potentially
eligible studies not captured by the electronic searches.
Two reviewers (I.S.T. and M.A.C.) independently
screened the title, abstract and reference list of each
study to locate potentially relevant studies, and once
hard copies of the screened documents were obtained.
The reviewers also attempted to identify articles that
met the selection criteria. A third external reviewer
(A.L.V.) was consulted to resolve discrepancies regarding
the selection process.
Data extraction and quality assessment
To guarantee the maximum objectivity possible, a code-
book was produced that specified the standards followed
in coding each of the characteristics of the studies. The
outcome measures were BG (mmol/L), HDL-C (mmol/L),
TG (mg/dL). SBP (mmHg), DBP (mmHg), and WC (cm).
A complete assessment of the level of risk of bias of
the included studies was made following The Cochrane
Collaboration’s tool for assessing the risk of bias in ran-
domised trials [38]. The methodological quality of the
studies selected was evaluated using the Physiotherapy
Evidence Database Scale (PEDro) [39]. A total score out
of 10 is derived for each study, adding the criteria that
are achieved, a PEDro score ranging from 6 to 10 is indi-
cative of high quality, 4–5 indicates fair quality, and
scores of 3 or less indicate poor quality [40]. To assess
the inter-coder reliability of the coding process, two re-
searchers coded all the selected studies, including meth-
odological quality assessment and risk of bias. For the
quantitative moderator variables, intra-class correlation
coefficients (ICCs) were calculated, whereas for the
qualitative moderator variables, Cohen’s kappa coeffi-
cients were applied. On average, the ICC was 0.96 (range
0.93–1.0) and the kappa coefficient was 0.98 (range
0.95–1.0), which can be considered highly satisfactory
[41]. The inconsistencies between the two coders were
resolved by consensus or by consulting with a third re-
viewer. The datasets used and/or analysed during the
current study are available from the corresponding au-
thor on reasonable request.
Table 1 Clinical cut off values of Metabolic Syndrome components
Component Clinical Cut Off Value
Blood Glucose OR (taking anti diabetic medication) > 100mg/dL
High-density lipoprotein OR (taking medication for reduced HDL-C) < 40mg/dL in males; < 50 mg/dL in females
Triglycerides > 150mg/dL
Systolic Blood Pressure / Diastolic Blood Pressure OR (taking anti-hypertensive medication) > 130mmHg / > 85mmHg
Waist Circumference > 102 cm in males; > 88 cm in femalesa
aIt is recommended that the International Diabetes Federation cut points be used for non-Europeans and either the International Diabetes Federation cut points
used for people of European origin until more data are available
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Statistical analysis
All outcomes were reported as means and standard devi-
ations (SD). The standardized mean differences (SMD)
were calculated to determine Cohen’s d for each study.
For each of the five outcome measures (BG, HDL-C,
TG, SBP, DBP and WC), an effect size was calculated as
the average difference between the post-test and pre-test
change scores of the experimental and control groups: D
¼ ðmEPost −mEPreÞ − ðmCPost −mCPreÞ [42]. Negative D values
indicated a better result for the intervention group
(INT) than for the control one. Separate meta-analyses
were performed for each outcome measure. For each, an
average effect size (D+) and a 95% CI were calculated by
assuming a fixed-effects model, with the inverse variance
as the weighting factor [43]. Heterogeneity of the effect
sizes across studies was assessed by means of Cochrane
Q statistic and the I2 index. A forest plot was also con-
structed for each meta-analysis. Lack of homogeneity
was considered for Cochrane Q tests with p < 0.10 and/
or for I2 indices. The forest plots were carried out with
the Review Manager (RevMan) software package (ver-
sion 5.5 for OSX, The Nordic Cochrane Centre, The
Cochrane Collaboration, 2014, Copenhagen, Denmark).
Results
Study selection
Our search strategy resulted in 2487 references. Of these,
954 were removed as duplicates after the first screening,
and 1482 references were removed based on the title and
abstract. Two other studies had duplicated data, 12 were
not randomised controlled trials, 14 studies did not apply
HIIT in their interventions, 10 did not include participants
Fig. 1 Flow chart of the selection studies in the meta-analysis
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with METS, and 3 did not have enough data to calculate
effect size. Finally, 10 studies that met the selection criteria
were identified [44–53]. Figure 1 shows the flow chart of
the selection process of studies.
Descriptive characteristics of the studies
The main characteristics of each of the studies are pre-
sented in Table 2. The studies selected were conducted
between 2007 and 2018. Six studies were carried out in
Spain, two in Norway, one in Iran, and one in Brazil. The
total sample size was 355 in the HIIT intervention groups
and 174 in the control groups. Two studies included only
men [51], one study included only women [44] and eight
trials included men and women [45–50, 52, 53]. The
length of the HIIT interventions ranged from 3 to 24
weeks and the weekly training frequency was 3 sessions
Table 2 Characteristics of the studies included in the meta-analysis
Paper/Country Participants/
Gender
Duration
(Weeks)
Frequency
(Days/week)
Exercise training characteristics Outcome
Alvarez et al.
2018 [44]
(Brazil)
HIIT
DYSHG: 12
CG: 12
Female
16 3 8 to 14 bouts of 30 to 58 s of jogging/
running at 90% HRreserve, interspersed
with recovery periods at 70% HRreserve
that lasted between 120 s and 96 s. The
number of bouts and the duration of
each interval increased every week,
duration of the recovery periods
shortened every week.
HIIT improved BG, HDL-C, TG, BP,
TC, LDL-C, endurance performance,
body composition and in women
in the DYSHG group.
Morales Palomo
et al. 2017 [45]
(Spain)
HIIT (TRAIN): 23
CG: 26
Mixed
16 3 4 bouts of 4 min of pedalling at 90% of
maximal HR interspersed with 3-min
active recovery periods at 70%
maximal HR.
HIIT reduced BG, SBP, DBP, WC, body
weight and BMI. TG levels were not
affected by training.
Morales Palomo
et al. 2019 [46]
(Spain)
HIIT (4HIIT): 32
CG: 22
Mixed
16 3 4 bouts of 4 min of pedalling at 90%
of maximal HR interspersed with 3-min
active recovery periods at 70% maximal
HR.
HIIT significantly reduced body
weight, WC and MAP. BG, HDL-C,
TG levels were not changed
significantly.
Mora Rodriguez
et al. 2017 [47]
(Spain)
HIIT (TRAIN): 23
CG: 23
Mixed
24 3 4 bouts of 4 min of pedalling at 90% of
maximal HR interspersed with 3-min
active recovery periods at 70%
maximal HR.
HIIT resulted in a significant decrease
in WC and mean arterial blood pressure.
No significant changes in BG, HDL-C
and TG levels in HIIT group.
Mora Rodriguez
et al. 2018a [48]
(Spain)
HIIT (TRAIN): 18
CG: 16
Mixed
24 3 4 bouts of 4 min of pedalling at 90%
of maximal HR interspersed with 3-min
active recovery periods at 70% maximal
HR.
HIIT resulted in a significant reduction
in body weight, percentage of body
fat, WC and MAP. HIIT did not elicit
changes in TG, BG and HDL-C.
Mora Rodriguez
et al. 2018b [49]
(Spain)
HIIT (TRAIN): 23
CG: 22
Mixed
16 3 4 bouts of 4 min of pedalling at 90% of
maximal HR interspersed with 3-min
active recovery periods at 70% maximal
HR.
HIIT resulted in significant decrease
in SBP, DBP and WC. No significant
changes in TG levels in HIIT group.
Mora Rodríguez
et al. 2019 [50]
(Spain)
HIIT (TRAIN): 76
CG: 20
Mixed
16 3 Twenty minutes continuous at 70%
of HRmax followed by 4 bouts of 3 min
of walking/running at 90% of HRmax
interspersed with a 3-min active recovery
at 70% of HRmax between intervals.
HIIT resulted in significant decrease
in BG, WC and MAP. No significant
changes in TG levels in HIIT group.
Sari-Sarraf et al.
2015 [53]
(Iran)
HIIT (HIIT2):11
CG: 11
Male
16 3 HIIT2: 5 bouts of 2 min cycling with
1-min recovery utilizing undulating
intensities (80–100% VO2peak).
HIIT resulted in significant decrease
in, BG, TG, SBP, DBP and WC. No
significant changes in HDL-C levels
in HIIT group.
Stensvold et al.
2010 [51]
(Norway)
HIIT (AIT): 11
CG: 11
Mixed
12 5 4 min intervals of walking/running at
90% of HRmax interspersed with 3 min
active recovery periods at 70% of
HRmax.
HIIT decreased SBP and DBP.
Tjønna et al.
2008 [52]
(Norway)
HIIT (AIT): 11
CG: 11
Mixed
16 4 4 bouts of 4 min of pedalling at 90%
of maximal HR interspersed with 3-min
active recovery periods at 70%
maximal HR.
HIIT resulted in significant decrease
in DBP, SBP, and WC. HDL-C
significantly increased in HIIT group.
No significant changes in TG and BG
levels in HIIT group.
BG Blood glucose, BP Blood Pressure, BMI Body Mass Index, CG Control group, DBP Diastolic blood pressure, DYSHG Dyslipidemia and high blood glucose, HBA1c
Haemoglobin A1c, HDL-C High-density lipoprotein, HR Heart rate, HRpeak Heart rate peak, HRreserve Heart rate reserve, HIIT High intensity interval training, LDL-C
Low-density lipoprotein, MAP Mean Arterial Pressure, MICT Moderate intensity continuous training, SBP Systolic blood pressure, TC Total Cholesterol, TG
Triglycerides, VO2peak Peak oxygen uptake, WC Waist circumference
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per week for 9 trials [44–51], 4 sessions per week in one
trial [53] and 5 sessions per week in another trial [54].
Type of exercise was cycling in 7 trials [45–49, 51, 53] and
walking/running on a treadmill in 3 trials [44, 50, 52].
Quality of the selected studies
The mean score obtained with the PEDro quality scale
was 6.7 (minimum score being 5, and the maximum
score being 7, higher scores indicating better quality).
All of the studies stated the eligibility criteria. Nine stud-
ies had the participants randomly allocated to groups,
and all had both groups matched at baseline. No studies
performed blinding of any kind to the subjects and/or
consultants that measure at least one variable. All stud-
ies reported results of between-groups statistical analysis
and provided point estimates for effect size. PEDro scale
of each study can be found in Appendix 2.
Risk of bias
The risk of bias was assessed with the Cochrane Risk of
Bias tool. The risk of bias assessment results can be ob-
served in Appendix 2. According to the Cochrane risk of
bias tool, most items (60%) were classified as low risk of
bias.
Effect sizes
Figures 2, 3, 4, 5, 6 and 7 show the main results and for-
est plots for each of the meta-analyses. Compared with
control groups, HIIT groups showed significant reduc-
tions in BG [D+ = − 0.11 mmol/L (95% CI: − 0.16 to −
0.06); p < 0.0001; SMD: -0.56 (95% CI: − 0.77 to − 0.34).
Fig. 2.], SBP [D+ = − 4.44mmHg (95% CI: − 6.82 to −
2.06); p = 0.0003; SMD: -0.48 (95% CI:-0.75 to − 0.20).
Fig. 3.], DBP [D+ = − 3.60 mmHg (95% CI: − 5.43 to −
1.78); p = 0.0001; SMD: -0.49 (95% CI:-0.76 to − 0.21).
Fig. 4.], and WC [D+ = − 2.26 cm (95% CI: − 3.12 to −
1.46); p < 0.00001; SMD: -0.44 (95% CI:-0.65 to − 0.23).
Fig. 5.] However, a significant increase was observed be-
tween groups for HDL-C [D+ = 0.02 mmol/L (95% CI:
0.00 to 0.02); p = 0.03; SMD: 0.00 (95% CI:-0.22 to 0.21).
Fig. 6]. No differences were found in TG [D+ = − 1.29
mg/dL (95% CI:: − 3.83 to 1.25); p = 0.32; SMD: -0.13
(95% CI:-0.35 to 0.09). Fig. 7].
Discussion
The primary finding of this meta-analysis was that HIIT
improved BG, SBP, DBP and WC in individuals with
MetS, however HDL-C increase slightly and it did not
have any effect on TG.
The reduction observed in BG after HIIT might be ex-
plained by increases in skeletal muscle mass, blood flow,
and insulin receptors, along with increased disposal of
glucose in the skeletal muscle, all as a function of the
physical exercise [54]. In addition, there is a known in-
crease in skeletal muscle GLUT-4 expression elicited by
training [55] which may be greater following HIIT
Fig. 2 Forest plot of mean difference in blood glucose (BG) of studies included
Fig. 3 Forest plot of mean difference in systolic blood pressure (SBP) of studies included
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compared to MICT [56, 57]. HIIT also results in greater
recruitment of type II skeletal muscle fibres [58], which
may explain the fact that exercise intensity correlates
positively with insulin sensitivity [59], an indication that
HIIT could potentially be more effective than MICT in
managing BG. In the long term, regular exercise, given
the acute inflammatory response to exercise partly medi-
ated by IL-6 may protect from low-grade inflammation
and thus against insulin resistance [60]. Observed effects
of aerobic exercise programs on glucose are similar to
those reported in HIIT interventions [61].
The HIIT reduction of SBP and DBP (~ 4mmHg) has
an important clinical impact, since decreases of as little
as 2 mmHg reduce the risk of developing coronary artery
diseases, myocardial infarction, stroke, and mortality in-
cidence [62–64]. Mechanisms for these reductions in
blood pressure are not entirely clear, although enhanced
baroreflex control of the sympathetic nerve activity, re-
duced circulation of catecholamines (norepinephrine),
reduced total peripheral resistance, and changes in vaso-
dilator and vasoconstrictor factors are plausible explana-
tions, as these are all elicited by exercise [65–67]. While
the role intensity plays on reducing SBP and DBP is not
fully understood, compared to other modes of training,
HIIT appears to be more potent in reducing SBP and
DBP [68, 69].
Lastly, HIIT resulted in a significant reduction in
WC of − 2.26 cm. It has been previously stated that a
reduction of 4 cm might be clinically relevant [70].
Intraabdominal adipose tissue is a major contributor
to MetS [71]. Despite not knowing the precise mecha-
nisms, it has been suggested that the WC reductions
might be linked to changes in excess post-exercise
oxygen consumption (EPOC), greater fat oxidation,
and changes in appetite and satiety mechanisms [72].
EPOC is positively correlated with exercise intensity,
thus HIIT has a more powerful effect on EPOC than
MICT [73]. Gaitanos et al. [74] suggests that HIIT re-
sults in greater fatty acids transport because during
the latter stages of HIIT sessions anaerobic glycogenol-
ysis is inhibited, resulting in ATP having to be
resynthesised mainly from PCr degradation and Trigly-
cerol stores. HIIT has also been reported to improve
appetite control by reducing average TNF-Alpha, PYY,
and Ghrelin concentrations, and increasing GLP-1
[75]. Another meta-analysis [76] reported a 3 cm re-
duction in WC induced by MICT in overweight and
obese individuals, showing similar decreases in com-
parison with the HIIT group in that particular meta-
analysis and slightly higher than in our study. Never-
theless, the effect of strength training alone on WC
has shown to be less potent (− 1.4 cm) [52].
Fig. 4 Forest plot of mean difference in diastolic blood pressure (DBP) of studies included
Fig. 5 Forest plot of mean difference in waist circumference (WC) of studies included
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The present meta-analysis showed a slight increase in
HDL-C and it did not find any changes in TG, which
agrees with a previous meta-analysis [61]. Compared to
MICT, HIIT is not superior in altering blood lipids in
adults [77], however the mechanisms behind this are not
clear and should be addressed in future studies.
The MetS variables that appear to be most sensitive to
HIIT are SBP and DBP, thus suggesting that HIIT as a
possible first-line treatment for BP. The other MetS vari-
ables improved by HIIT improved by the same magnitude
as seen with MICT. However, the nature of HIIT is that
sessions require less time and often offer greater enjoy-
ment and may therefore be more efficient than MICT.
Despite the mounting evidence that favours using
HIIT to improve indices of cardiometabolic health, the
potential impact on public health is still subject to de-
bate regarding its safety and adequacy in terms of enjoy-
ment and adherence [27]. Some research in the past has
claimed that there is a negative relationship between ex-
ercise intensity and affect, thus suggesting this could be
detrimental for exercise adherence [78, 79]. However, a
recent meta-analysis and systematic review reported that
positive affective responses may be obtained from HIIT
[33], the rest intervals in HIIT may be responsible for
this response by helping reduce discomfort [80]. Recent
data show that in healthy non-obese individuals, HIIT is
more enjoyable than prolonged continuous exercise due
to it being more time-efficient and because of the
repeated stimulus changes [81]. On overweight individ-
uals, HIIT is as enjoyable as MICT and with high adher-
ence rates while being performed unsupervised [82].
Also, HIIT appears to become more enjoyable as the train-
ing advances, while MICT enjoyment levels remain un-
changed as the weeks progress [83], suggesting that in the
long term, HIIT appears to be a more suitable mode of ex-
ercise. In this meta-analysis there was no drop out differ-
ence between control and intervention groups. Data
regarding safety of HIIT against MICT shows there are
slightly more adverse events following HIIT sessions than
MICT sessions [28]. However, a small sample size was
employed, thus further research is needed to assess safety
of HIIT. Future research should, therefore, focus on opti-
mal training thresholds for HIIT that are effective, enjoy-
able, and feasible outside to ensure the greatest public
health impact.
Limitations
There are a number of limitations that may affect this
meta-analysis that should be taken into consideration.
First of all, the sample size of each included study was
small, and some scientific criteria were not indicated in
some studies, such as lack of follow-up and control of
the group activities in the non-exercise groups. Other
limitations were that studies employed heterogeneous
HIIT protocols, with different duration of bouts and dif-
ferent modes of exercise.
Fig. 6 Forest plot of mean difference in high-density lipoprotein (HDL-C) of studies included
Fig. 7 Forest plot of mean difference in triglycerides (TG) of studies included.
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Conclusions
HIIT interventions showed significant physiological ben-
efits for BG, SBP, DBP and WC reductions, potentially
linked with changes in skeletal muscle’s oxidative cap-
acity, arterial peripheral resistance, and EPOC. However,
no significant differences were observed between experi-
mental and control groups for TG and HDL-C increased
in a non-relevant way. Therefore, HIIT has the potential
to have a public health impact on critical components of
the metabolic syndrome. In addition, the reduced time
commitment of HIIT and equal if not better levels of en-
joyment may make HIIT even better than MICT on an
individual and population level. There is, however, still a
need for additional research to determine the causal
mechanism producing the beneficial metabolic changes,
and also to assess minimum HIIT thresholds in regard
to frequency, rest intervals, etc., to produce optimal
outcomes.
Appendix 1
Analysis of the selected studies’ methodological quality
(n = 10).
Study 1 2 3 4 5 6 7 8 9 10 11 Score
Alvarez et al. 2018 [44] + – – + – – – + + + + 5
Morales-Palomo et al.
2017 [45]
+ + + + – – – + + + + 7
Morales-Palomo et al.
2019 [46]
+ + + + – – – + + + + 7
Mora Rodriguez et al.
2017 [47]
+ + + + – – – + + + + 7
Mora Rodriguez et al.
2018a [48]
+ + + + – – – + + + + 7
Mora Rodriguez et al.
2018b [49]
+ + + + – – – + + + + 7
Mora Rodriguez et al.
2019 [50]
+ + + + – – – + + + + 7
Sari-Sarraf et al. 2015 [53] + + + + – – – + + + + 7
Stensvold et al. 2010 [51] + + + + – – – + + + + 7
Tjønna et al. 2008 [52] + + – + – – – + + + + 6
The numbers of the columns corresponded to the
following items of the PEDro scale:
1. Eligibility criteria were specified (not included in
score).
2. Subjects were randomly allocated to groups.
3. Allocation was concealed.
4. The groups were similar at baseline regarding the
most important prognostic indicator.
5. There was blinding of all subjects.
6. There was blinding of all therapists who
administered the therapy.
7. There was blinding of all consultants who measured
at least one key outcome.
8. Measures of at least one key outcome were
obtained from more than 85% of the subjects
initially allocated to groups.
9. All subjects for whom outcome measures were
available received the treatment or control
condition as allocated or, where this was not the
case, data for at least one key outcome was analysed
by intention to treat.
10. The results of between-group statistical
comparisons are reported for at least one key
outcome.
11. The study provides both point measures and
measures of variability for at least one key outcome.
Appendix 2
Cochrane risk of bias tool of the selected studies
(n = 10).
Study 1 2 3 4 5 6
Alvarez et al. 2018 [44] + – – – + +
Morales-Palomo et al. 2017 [45] + + – – + +
Morales-Palomo et al. 2019 [46] + + – – + +
Mora Rodriguez et al. 2017 [47] + + – – + +
Mora Rodriguez et al. 2018a [48] + + – – + +
Mora Rodriguez et al. 2018b [49] + + – – + +
Mora Rodriguez et al. 2019 [50] + + – – + +
Sari-Sarraf et al. 2015 [53] + + – – + +
Stensvold et al. 2010 [51] + + – – + +
Tjønna et al. 2008 [52] + – – – + +
Risk of bias assessment of the included studies. (+)
indicates low risk of bias, (?) indicates unclear risk of
bias, (−) indicates high risk of bias:
1. Random sequence generation (Selection bias).
2. Allocation concealment (Selection bias).
3. Blinding (participants and personnel) (Performance
bias).
4. Blinding (outcome assessment) (Detection bias).
5. Incomplete outcome data (Attrition bias).
6. Selective reporting (Reporting bias).
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